Christian Aid and Gilead Sciences are working together to reduce HIV-related stigma and discrimination. In Nigeria, we’re promoting the adoption and implementation of the SAVE approach to tackle HIV and AIDS.
Nigeria is the most populous nation in Africa with an estimated population of 170 million people. It has the world’s second highest number of new HIV infections reported each year, and an estimated 3.7% of the population is living with HIV2.
According to government reports, every year more than 300,000 Nigerians die from complications arising from AIDS. National life expectancy is low at 52 years, but this figure has been rising since access to antiretroviral therapy became available in the mid-2000s.
Through our partnership with Gilead, we hope to:
- achieve an increased uptake of HIV testing and counselling and antiretroviral therapy
- encourage more people living with HIV to be open about their status and act as advocates for testing and access to treatment in their communities
If you would like to partner with Christian Aid please email privatesectorteam@christian-aid.org or call 020 789 8934.
For more information about Gilead Sciences, visit gilead.com